Related Experiment Videos
Cat eye syndrome with hypogonadotropic hypogonadism
H Masukawa1, T Ozaki, T Nogimori
1Department of Internal Medicine, Konan Showa Hospital, Nagoya.
Internal Medicine (Tokyo, Japan)
|December 5, 1998
Summary
Cat Eye Syndrome (CES) in a male adolescent with hypogonadotropic hypogonadism was treated with gonadotropin therapy, effectively resolving short stature and androgen deficiency. Further research is needed to identify other potential chromosomal abnormalities.
Area of Science:
- Genetics
- Endocrinology
- Pediatrics
Background:
- Cat Eye Syndrome (CES) is a rare chromosomal disorder characterized by specific facial abnormalities and potential developmental issues.
- Hypogonadotropic hypogonadism is a condition characterized by the failure of the gonads to produce adequate sex hormones, leading to delayed or absent puberty.
Observation:
- A 17-year-old male with Cat Eye Syndrome presented with short stature and lack of secondary sex characteristic development.
- The patient was diagnosed with hypogonadotropic hypogonadism, a common endocrine complication associated with CES.
Findings:
- Treatment with exogenous gonadotropin replacement therapy, including human chorionic gonadotropin (hCG) and human menopausal gonadotropin (hMG), was initiated.
- The therapy successfully alleviated the patient's short stature and corrected the androgen deficiency.
Implications:
- This case highlights the efficacy of gonadotropin therapy in managing endocrine complications of Cat Eye Syndrome.
- Tetrasomy of chromosome 22 pter-->q11 is identified as the critical region for CES, but other chromosomal abnormalities may contribute to hypogonadotropic hypogonadism, necessitating further investigation.